REG - Hikma Pharmaceutical - Director/PDMR Shareholding

Hikma PharmaceuticalsAnnouncement

24/03/2020 10:55

RNS Number : 3696H
  
Hikma Pharmaceuticals Plc
  
24 March 2020
  
 

Notification and public disclosure of transactions by persons discharging managerial responsibilities



1


Details of the person discharging managerial responsibilities / person closely associated




a)


Name


Cynthia Schwalm




2


Reason for the notification




a)


Position/status


Non-Executive Director




b)


Initial notification /Amendment


Initial notification




3


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name


Hikma Pharmaceuticals PLC




b)


LEI


549300BNS685UXH4JI75




4


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




a)


Description of the financial instrument, type of instrument and identification code


Description: Ordinary shares of 10 pence each (Shares)
ID Code: GB00B0LCW083




b)


Nature of the transaction
 


Market purchase of 1,100 Ordinary Shares by Cynthia Schwalm 




c)


Price(s) and volume(s)


Price(s): £18.19
Volume(s): 1,100




d)


Aggregated information
-       Volume



-       Price















1,100







£20,009




e)


Date of the transaction


20 March 2020




f)


Place of the transaction


London Stock Exchange (XLON)



 
Peter Speirs

Company Secretary, responsible for releasing this announcement

+44 (0) 20 7399 2760
24 March 2020


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
DSHBGGDXBUDDGGS